Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 7 Issue 5, May 2011

Mutation of the tumor suppressor p53 results in dominant-negative activities that cannot be fully explained by current models. Xu et al. report a mechanism explaining how mutation of p53 can structurally destabilize the DNA-binding domain and increase the exposure of an aggregation nucleation sequence. This can trigger an aggregation cascade involving not only wild-type p53 but its homologs p63 and p73. The image depicts the destabilization that exposes the aggregating sequence and the formation of inactive protein aggregates. The photo of Van Gogh’s The Starry Night was obtained from Google Art Project and adapted by Jie Xu. Cover art by Erin Dewalt. Article, p285; News & Views, p248

Editorial

  • Unsupported assumptions have no place in scientific research, so why should they be tolerated when judging the talents and motivations of women in science?

    Editorial

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • A small subpeptide from the tumor suppressor p53 is shown to mediate aggregation that is similar to that of amyloids. The result is nucleated assembly by mutant p53 that can abrogate function of wild-type p53 and its two functionally important homologs.

    • Mazin Magzoub
    • Andrew D Miranker
    News & Views
  • Classical cannabinoid receptors do not mediate all actions of the active drug in cannabis, THC. Here the mechanism by which THC enhances glycine receptor activity has been identified and used to design new pain therapeutics that avoid THC's adverse effects.

    • MacDonald J Christie
    • Christopher W Vaughan
    News & Views
  • Parathyroid hormone analog PTH(1–34), used clinically to treat osteoporosis, forms a stable complex with its receptor and prolongs cAMP production even after internalization and recruitment to endosomes. New data suggest this signaling cascade is stimulated by β-arrestins and terminated by retromer.

    • Jan R T van Weering
    • Peter J Cullen
    News & Views
  • Directed evolution of nucleic acids and proteins in the laboratory can produce many novel phenotypes in a relatively short time frame. A significant enhancement to these techniques allows continuous evolution in special turbidostats and can speed the discovery of proteins with desirable activities.

    • Niles Lehman
    News & Views
Top of page ⤴

Brief Communication

  • A selective, short-acting agonist for the sphingosine-1-phosphate receptor S1P1 and GFP-S1P1 knock-in mouse model are used to show that both receptor degradation and receptor reserve underlie the mechanisms of lymphocyte sequestration by agonists.

    • Stuart M Cahalan
    • Pedro J Gonzalez-Cabrera
    • Hugh Rosen
    Brief Communication
  • Experiments on reconstituted liposomes and sperm capacitation, an activation process involving the reduction in membrane cholesterol content and subsequent exposure of surface carbohydrate, show that cholesterol masks the presentation of glycolipid head groups by inducing a conformational shift in the glycan moiety.

    • Daniel Lingwood
    • Beth Binnington
    • Kai Simons
    Brief Communication
Top of page ⤴

Article

  • Magic-angle spinning ssNMR used to monitor the E. coli integral membrane protein DGK reconstituted into lipid bilayers reveals the kinetics and mechanisms of this enzyme in both the membrane phase where diacylglycerol is converted to PA and in the aqueous phase where ATP is converted to ADP.

    • Sandra J Ullrich
    • Ute A Hellmich
    • Clemens Glaubitz
    Article
  • Metabolic engineering often involves the addition of enzymes, redirection of metabolic flux or elimination of undesirable endpoints and thus requires laborious optimization of numerous parameters. A new method to derive 'blueprints' from real-time measurements of metabolic networks significantly accelerates this process as demonstrated with the production of dihydroxyacetone phosphate.

    • Matthias Bujara
    • Michael Schümperli
    • Sven Panke
    Article
  • Going against the classical model of β-arrestin–mediated internalization and downregulation of GPCRs, FRET, FRAP and time-lapse imaging show that PTHR remains active when bound to β-arrestin and is ultimately terminated by retromer complex, a complex involved in transport from endosomes to the Golgi.

    • Timothy N Feinstein
    • Vanessa L Wehbi
    • Jean-Pierre Vilardaga
    Article
  • Mutant p53 can attenuate the function of wild-type p53, p63 and p73. An aggregation-nucleating sequence in p53 that is revealed in structurally destabilized mutants can induce coaggregation with p63 and p73, resulting in their sequestration in cellular inclusions.

    • Jie Xu
    • Joke Reumers
    • Joost Schymkowitz
    Article
  • Synthesis of new vancomycin-like glycopeptides offers opportunities to overcome antibiotic resistance. The crystallographic identification of a reaction intermediate close to the surface of a glycopeptide tailoring enzyme leads to a new biocatalytic strategy to create two classes of teicoplanin analogs.

    • Yu-Chen Liu
    • Yi-Shan Li
    • Tsung-Lin Li
    Article
  • Hydrogenases can generate hydrogen gas, but oxygen sensitivity often limits their practical applications. Investigations of an oxygen-tolerant [NiFe] hydrogenase now show that an unusual FeS cluster with six cysteine ligands alters the electron pathway to reduce unwanted oxygen and maintain enzyme function.

    • Tobias Goris
    • Annemarie F Wait
    • Oliver Lenz
    Article
Top of page ⤴

Corrigendum

Top of page ⤴

Search

Quick links